# US 2025/0082440 A1 · Composition for Isolating Tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082440 A1
- Document ID: US20250082440A1
- Status: Published application
- Kind: A1
- Application number: 18/580,190
- Filed: 2022-07-18
- Published: 2025-03-13
- Earliest claimed: 2021-08-05
- Assignees: 3M Innovative Properties Company
- Applicants: 3M Innovative Properties Company
- Inventors: Henning Hoffmann; Peter Osswald; Ruediger Hampe
- Web page: https://patentgrep.com/patent/US20250082440A1

## CPC

- A61C 5/82: Dams; Holders or clamps therefor
- A61L 31/041: {Mixtures of macromolecular compounds}
- A61C: DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE (non-driven toothbrushes A46B; {tongue scrapers A61B17/24;} preparations for dentistry A61K6/00; preparations for cleaning the teeth or mouth A61K8/00, A61Q11/00)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

The invention relates to a composition for isolating tissue, the composition comprising a radiation curable component A1, preferably being present in an amount of at least 40 wt. % with respect to the composition, the radiation curable component A1 comprising a polyether polyol spacer group having a molecular weight (Mw) of 1,000 to 20,000 g/mol, and at least two (meth)acrylate moieties, photo-initiator, guanidyl containing polymer, carrageenan, optionally softener, optionally dye, optionally filler, optionally additives. The invention also relates to a process for temporarily isolating tissue, the process comprising the steps of providing the composition described in any of the preceding claims, placing the composition in contact with tissue, radiation curing the composition at least partially for a time period T1, optionally moving or adjusting the partially cured composition, optionally radiation curing the partially cured composition for a time period T2, wherein T2>T1, removing the composition from the tissue.

## Claims

### Claim 1

A composition for isolating tissue, the composition comprising
a radiation curable component A1, preferably being present in an amount of at least 40 wt. % with respect to the composition, the radiation curable component A1 comprising a polyether polyol spacer group having a molecular weight Mw of 1,000 to 20,000 g/mol, and at least two (meth)acrylate moieties, photo-initiator, guanidyl containing polymer, carrageenan, optionally softener,
optionally dye, optionally filler, and optionally additives,
the composition having preferably a viscosity of less than 200 Pa*s at 23° C. and a shear rate of 50s−1.

### Claim 2 (depends on 1)

The composition of claim 1 the ratio of radiation curable component A1 to guanidyl containing polymer being in a range of 10:1 to 5:1 with respect to weight.

### Claim 3 (depends on 1)

The composition of claim 1, the ratio of guanidyl containing polymer to carrageenan being in a range of 2:1 to 1:2 with respect to weight.

### Claim 4 (depends on 1)

The composition of claim 1 comprising the components in the following amounts:
radiation curable component A1: 40 to 90 wt. %,
photo-initiator: 0.1 to 5 wt. %,
guanidyl containing polymer: 2 to 10 wt. %,
carrageenan: 2 to 10 wt. %,
softener: 0 to 20 wt. %,
dye: 0 to 5 wt. %,
filler: 0 to 10 wt. %,
additives: 0 to 10 wt. %
wt. % with respect to the weight of the whole composition.

### Claim 5 (depends on 1)

The composition according to claim 1 comprising a radiation curable component A1 and a radiation curable component A2 having a molecular weight in the range of 130 to 800 g/mol and being present in an amount lower than the amount of radiation curable component A1.

### Claim 6 (depends on 1)

The composition of claim 1 comprising softener, the softener having a molecular weight Mw of less than 1,000 g/mol and being preferably selected from glycol, glycerine, ethylene glycol, poly(ethylene glycol), propylene glycol, poly(propylene glycol), and mixtures thereof.

### Claim 7 (depends on 1)

The composition of claim 1 comprising dye, the dye being characterized by the following features alone or in combination:
having a light absorption maximum in the range of 420 to 600 nm;
comprising a perylene or naphtalimide moiety;
being a fluorescent dye.

### Claim 8 (depends on 1)

The composition of claim 1 comprising in addition a urethan (meth)acrylate, preferably a urethan (meth)acrylate having a molecular weight (Mw) in the range of 200 to 1,000 g/mol.

### Claim 9 (depends on 1)

The composition of claim 1 being characterized by the following features alone or in combination before hardening:
radiation curable with light having a wavelength in the range of 430 to 500 nm;
viscosity: less than 200 Pa*s at 23° C. and a shear rate of 50 s−1;
pH value: 5 to 8 if brought in contact with water;
water-uptake capacity: 25 to 450 wt. %;
extrusion force: 150 N or less, if the composition is dispensed from a container having a cannula with the dimension shown in FIG. 4 and using a piston as shown in FIGS. 5 and 6 of WO 2010/138433 A1.

### Claim 10 (depends on 1)

The composition of claim 1 being characterized by the following features alone or in combination after hardening:
tensile strength: 2 to 10 MPa according to ISO/DIN 53504 (2015-8);
elongation at break: 40 to 200% according to ISO/DIN 53504 (2015-8);
Shore hardness A: 30 to 90 according to ISO/DIN 53505 (2000-8);
depth of cure: 2 to 8 mm according to DIN EN ISO 6874 (2015).

### Claim 11 (depends on 1)

The composition of claim 1 being characterized as follows:
the radiation curable component A1 not comprising a urethane moiety being present in an amount of 40 to 90 wt. %,
the urethan (meth)acrylate having a molecular weight in the range of 200 to 1,000 g/mol, and being present in an amount of 0 to 35 wt. %,
the photo-initiator being present in an amount of 0.1 to 5 wt. %,
the guanidyl containing polymer being selected from polymers of the following formula and mixtures thereof,
with X− being selected from Cl−, Br−, I−, ½SO42−, NO3−, CH3COO−, C3H7COO−, and being present in an amount of 2 to 10 wt. %, and
the carrageenan being selected from iota-carrageenan or lambda carrageenan, and being present in an amount of 2 to 10 wt. %,
the softener having a molecular weight (Mn) less than 1,000 g/mol, and being selected from glycol, glycerine, ethylene glycol, poly(ethylene glycol), propylene glycol, poly(propylene glycol), copolymer(s) of ethylene glycol, propylene glycol and/or tetrahydrofuran and mixtures thereof, and being present in an amount of 0 to 20 wt. %,
the dye having a light absorption maximum in the range of 420 to 600 nm, and being present in an amount of 0.1 to 5 wt. %,
the filler being selected from silica, alumina, magnesia, titania, silicates and mixtures thereof, and being present in an amount of 1 to 10 wt. %,
additives being present in an amount of 0 to 10 wt. %,
wt. % with respect to the weight of the whole composition.

### Claim 12 (depends on 1)

A packaging device containing the composition of claim 1, the packaging device comprising a dispensing nozzle and a reservoir for storing the composition, the reservoir having a volume of 0.5 to 10 ml, the dispensing nozzle having an internal diameter at the opening of 0.2 to 1 mm.

### Claim 13 (depends on 1)

A process for temporarily isolating tissue, the process comprising the steps of providing the composition of claim 1
placing the composition in contact with tissue,
radiation curing the composition at least partially for a time period T1,
optionally moving or adjusting the partially cured composition,
optionally radiation curing the partially cured composition for a time period T2, wherein T2>T1, removing the composition from the tissue.

### Claim 14 (depends on 13)

The process of claim 13, the curing being done in at least two steps, a first step for a time period T1 and a second step for a time period T2, the first and second step differing from each other by either the duration of radiation, or the intensity of radiation, or a combination of both.

### Claim 15 (depends on 1)

A kit of parts comprising the composition described in claim 1 and the following items alone or in combination: dental curing light, dental restoration material, dental adhesive, dental cement, dental matrix equipment.
